Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Enhanced bioavailability of oral paclitaxel by valspodar (PSC 833), an inhibitor of small bowel P-glycoprotein and cytochrome P450. Sikic, B. I., Advani, R., Fisher, G. A., Halsey, J., Cohen, P., Lum, B. L. AMER ASSOC CANCER RESEARCH. 2000: 4580S
View details for Web of Science ID 000165409000528